dangers of glp 1 drugs Do GLP-1 Reduce Visceral Fat? Evidence and Clinical Insights Your guide to GLP-1 side

Gastrointestinal (GI) side effects are also common in GLP-1 therapies and are a leading cause of treatment discontinuation [[10], [11], [12]]

10.1007/s40200-023-01309-y 9 BaileyC

Artefacts with ascorbate and other redox-active compounds in cell culture: epigenetic modifications, and cell killing due to hydrogen peroxide generation in cell culture media

With intestinal disease (including bypass operations that may be performed to treat obesity), increased fecal loss of bile acids leads to decreased concentrations of both primary and secondary bile acids and, often, a decrease in cholesterol caused by increased need for bile acid synthesis

Leptin resistance: underlying mechanisms and diagnosis